TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Capra Science Antibodies AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,474
|
5,166
|
5,771 |
| Financial expenses |
46
|
36
|
12 |
| Earnings before taxes |
186
|
200
|
679 |
| EBITDA |
745
|
577
|
952 |
| Total assets |
4,579
|
3,897
|
4,758 |
| Current assets |
2,159
|
1,947
|
2,759 |
| Current liabilities |
1,059
|
972
|
1,863 |
| Equity capital |
2,690
|
2,543
|
2,385 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.7%
|
65.3%
|
50.1% |
| Turnover per employee |
1,825
|
1,722
|
1,924 |
| Profit as a percentage of turnover |
3.4%
|
3.9%
|
11.8% |
| Return on assets (ROA) |
5.1%
|
6.1%
|
14.5% |
| Current ratio |
203.9%
|
200.3%
|
148.1% |
| Return on equity (ROE) |
6.9%
|
7.9%
|
28.5% |
| Change turnover |
308
|
-605
|
-5 |
| Change turnover % |
6%
|
-10%
|
0% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-25% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.